Pavel, M., Baudin, E., Öberg, K., Hainsworth, J., Voi, M., Rouyrre, N., . . . Yao, J. (2017). Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: Final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study. Ann Oncol.

Pavel, M.E., E. Baudin, K.E Öberg, J.D Hainsworth, M. Voi, N. Rouyrre, M. Peeters, D.J Gross, und J.C Yao. "Efficacy of Everolimus Plus Octreotide LAR in Patients With Advanced Neuroendocrine Tumor and Carcinoid Syndrome: Final Overall Survival From the Randomized, Placebo-controlled Phase 3 RADIANT-2 Study." Ann Oncol 2017.

Pavel, M.E., et al. "Efficacy of Everolimus Plus Octreotide LAR in Patients With Advanced Neuroendocrine Tumor and Carcinoid Syndrome: Final Overall Survival From the Randomized, Placebo-controlled Phase 3 RADIANT-2 Study." Ann Oncol 2017.